A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis

A comparison of aspirin against rivaroxaban for venous thromboembolism prophylaxis after hip or knee arthroplasty: A meta-analysis

Purpose: Total knee arthroplasty (TKA) and total hip arthroplasty (THA) patients are at an elevated risk of post-operative venous thromboembolism (VTE). Newer thromboprophylactic agents such as rivaroxaban are increasingly used and effective in preventing thromboembolic events but may worsen bleedin...

Full description

Bibliographic Details
Main Authors:	Joshua Xu, Aran Kanagaratnam, Jacob Y Cao, Gurpreet S Chaggar, Warwick Bruce
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-01-01
Series:	Journal of Orthopaedic Surgery
Online Access:	https://doi.org/10.1177/2309499019896024

Similar Items

Venous thromboembolism prophylaxis after total knee arthroplasty (TKA): aspirin vs. rivaroxaban
by: Jose Luiz Colleoni, et al.

An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020
by: Daniel C. Santana, et al.
Published: (2020-08-01)

RANDOMIZED CLINICAL TRIAL OF ASPIRIN AS PROPHYLAXIS FOR THROMBOEMBOLISM IN HIP ARTHROPLASTY
by: Raul Carneiro Lins, et al.
Published: (2024-03-01)

PROSPECTIVE STUDY OF ASPIRIN FOR THROMBOEMBOLISM PROPHYLAXIS IN TOTAL HIP ARTHROPLASTY
by: RAUL CARNEIRO LINS, et al.
Published: (2018-04-01)

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 3. Pharmacological venous thromboembolism prophylaxis
by: Satit Thiengwittayaporn, et al.
Published: (2021-08-01)

Rivaroxaban versus aspirin in prevention of venous thromboembolism following total joint arthroplasty or hip fracture surgery: a meta-analysis
by: Bangsheng Hu, et al.
Published: (2021-02-01)

Asia-Pacific venous thromboembolism consensus in knee and hip arthroplasty and hip fracture surgery: Part 2. Mechanical venous thromboembolism prophylaxis
by: Chavarin Amarase, et al.
Published: (2021-06-01)

Is aspirin enough for venous thromboembolism prophylaxis?
by: Niels D Martin, et al.
Published: (2024-09-01)

Aspirin versus Rivaroxaban to Prevent Venous Thromboembolism after Total Knee Arthroplasty: A Double-blinded, Randomized Controlled Trial
by: Theerawit Hongnaparak, et al.
Published: (2022-11-01)

Prevention of Venous Thromboembolism in Hip and Knee Arthroplasty
by: Mario Ponikvar, et al.
Published: (2010-03-01)

Is aspirin still relevant as a single pharmacological agent for venous thromboembolism prophylaxis post hip and knee arthroplasty surgery: A retrospective review
by: Pretorius Jacques, et al.
Published: (2022-01-01)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
by: Levitan B, et al.
Published: (2014-03-01)

Should prophylaxis of venous thromboembolism in Asian patients undergoing knee and hip arthroplasty and hip fracture surgery be an issue?
by: Aree Tanavalee
Published: (2021-07-01)

Pharmacologic Prophylaxis and Treatment of Venous Thromboembolism after Knee Arthroplasty
by: Jamal S Shawabkeh, et al.
Published: (2007-04-01)

Venous Thromboembolism Prophylaxis with Rivaroxaban in Elective Foot and Ankle Surgery
by: Martin J. Wiewiorski MD, et al.
Published: (2016-08-01)

Incidence of silent venous thromboembolism after total hip arthroplasty: A comparison of rivaroxaban and enoxaparin
by: Wael A. Rahman, et al.
Published: (2020-07-01)

Time for an Update? A Look at Current Guidelines for Venous Thromboembolism Prophylaxis After Hip and Knee Arthroplasty and Hip Fracture
by: Stefano R. Muscatelli, MD, et al.
Published: (2021-08-01)

Venous thromboembolism rates after hip and knee arthroplasty and hip fractures
by: Viswanath Mula, et al.
Published: (2020-02-01)

Venous thromboembolism and its prophylaxis in elective knee arthroplasty: An international perspective
by: Khokhar, A, et al.
Published: (2012)

Venous thromboembolism and its prophylaxis in elective knee arthroplasty: an international perspective.
by: Khokhar, A, et al.
Published: (2013)

Aspirin is Not for Everyone: Discharge to Non-home Facilities After Total Hip and Knee Arthroplasty Increases Risk of Venous Thromboembolism
by: Michael McHugh, MD, et al.
Published: (2024-06-01)

Safety of Peri-Operative Low-Dose Aspirin as a Part of Multimodal Venous Thromboembolic Prophylaxis for Total Knee and Hip Arthoplasty
by: David J Cossetto, et al.
Published: (2012-12-01)

Comparison of the Efficacy and Safety of Aspirin and Rivaroxaban Following Enoxaparin Treatment for Prevention of Venous Thromboembolism after Hip Fracture Surgery
by: Qiang Huang, et al.
Published: (2019-10-01)

Comparison of Enoxaparin and Rivaroxaban in the Prophylaxis of Deep Venous Thrombosis in Arthroplasty
by: Necati Çiçek, et al.
Published: (2021-01-01)

Quality appraisal of clinical guidelines for venous thromboembolism prophylaxis in patients undergoing hip and knee arthroplasty: a systematic review
by: Yu Wang, et al.
Published: (2020-12-01)

Venous thromboembolism and its prophylaxis in elective total hip arthroplasty: an international perspective.
by: Chari, A, et al.
Published: (2012)

Pharmacoeconomic study on rivaroxaban vs conventional venous thromboembolism prophylaxis following elective total hip or knee replacement surgery in Serbia: Single centre study
by: Perović Saša R., et al.
Published: (2017-01-01)

Increased incidence of venous thromboembolism following hip or knee arthroplasty in winter
by: Christopher Wynne Jones, et al.
Published: (2020-04-01)

Comparative efficacy of aspirin versus direct oral anticoagulants for venous thromboembolism prophylaxis following primary total hip arthroplasty or total knee arthroplasty: A systematic review and meta‐analysis of randomised controlled trials
by: Fauzaan Ali Syed, et al.
Published: (2024-07-01)

Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
by: Kwong LM
Published: (2013-08-01)

Rivaroxaban for venous thromboembolism prophylaxis in abdominoplasty after massive weight loss: 396 cases
by: Guilherme Berto Roça, et al.
Published: (2019-06-01)

New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis
by: Yi-hu Yi, et al.
Published: (2022-01-01)

Comparative effectiveness of aspirin for symptomatic venous thromboembolism prophylaxis in patients undergoing total joint arthroplasty, a cohort study
by: Verinder Sidhu, et al.
Published: (2023-08-01)

Thirty day low-dose versus regular-dose aspirin for venous thromboembolism prophylaxis in primary total joint arthroplasty
by: Alexander J. Duke, et al.
Published: (2023-05-01)

Simulation of the economic impact of introducing rivaroxaban in a high-complexity hospital for venous thromboembolism prophylaxis
by: Diovanna Santos DE CARVALHO, et al.
Published: (2024-07-01)

CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study
by: Rachelle Buchbinder, et al.
Published: (2019-11-01)

Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials
by: Matharu, G, et al.
Published: (2020)

Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
by: Kochawan Boonyawat, et al.
Published: (2021-02-01)

Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01)

Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data
by: Kwong LM
Published: (2011-07-01)